(Q44319013)

1 December 2017

Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice (English)

1 reference

1 December 2017

1 reference

1 reference

15

Naoki Mochizuki

1 reference

1 December 2017

Ayako Takahashi

1

1 reference

1 December 2017

Masanori Asakura

2

1 reference

1 December 2017

Shin Ito

3

1 reference

1 December 2017

Kyung-Duk Min

4

1 reference

1 December 2017

Kazuhiro Shindo

5

1 reference

1 December 2017

Yi Yan

6

1 reference

1 December 2017

Yulin Liao

7

1 reference

1 December 2017

Satoru Yamazaki

8

1 reference

1 December 2017

Shoji Sanada

9

1 reference

1 December 2017

Yoshihiro Asano

10

1 reference

1 December 2017

Hatsue Ishibashi-Ueda

11

1 reference

1 December 2017

Seiji Takashima

12

1 reference

1 December 2017

Tetsuo Minamino

13

1 reference

1 December 2017

Hiroshi Asanuma

14

1 reference

1 December 2017

Masafumi Kitakaze

16

1 reference

1 December 2017

15 March 2013

1 reference

American Journal of Physiology Heart and Circulatory Physiology

1 December 2017

1 reference

1 December 2017

304

1 reference

1 December 2017

10

1 reference

1 December 2017

H1361-9

1 reference

Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey.

1 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Metabolic mechanisms in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Progression of left ventricular diastolic dysfunction and risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Abnormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Effects of DPP-4 inhibition on cardiac metabolism and function in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Mechanisms of insulin resistance in humans and possible links with inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Assessing the cardio-cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

High multivitamin intake by Wistar rats during pregnancy results in increased food intake and components of the metabolic syndrome in male offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

The association between glucose abnormalities and heart failure in the population-based Reykjavik study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00454.2012

10.1152/AJPHEART.00454.2012

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference